Patients' views about taking a polypill to manage cardiovascular risk: A qualitative study in primary care

British Journal of General Practice

Volumn 65, Issue 636, 2015, Pages e447-e453

  Virdee, Satnam K ^a   Greenfield, Sheila M ^a   Fletcher, Kate ^a   McManus, Richard J ^b   Mant, Jonathan ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Blood pressure; Cardiovascular disease; Cholesterol; Patients' Views; Polypill; Prevention; Primary care; Risk factors.

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOVASCULAR AGENT; DRUG COMBINATION;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; MALE; MANAGED CARE; MIDDLE AGED; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SATISFACTION; PILL; POLYPILL; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; QUALITATIVE ANALYSIS; QUALITATIVE RESEARCH; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SEMI STRUCTURED INTERVIEW; TREATMENT INDICATION; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; DRUG COMBINATION; DRUG MONITORING; FOLLOW UP; MORBIDITY; MULTICENTER STUDY; PHYSIOLOGIC MONITORING; PRIMARY HEALTH CARE; PROCEDURES; TRENDS; UNITED KINGDOM;

AGED; ATTITUDE TO HEALTH; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DRUG COMBINATIONS; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MORBIDITY; PRIMARY HEALTH CARE; QUALITATIVE RESEARCH; RISK FACTORS; UNITED KINGDOM;

EID: 84937692966     PISSN: 09601643     EISSN: 14785242     Source Type: Journal    
DOI: 10.3399/bjgp15X685657     Document Type: Article

References (34)

1. Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death. Br Med Bull 2009; 92: 7-32.
2. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network metaanalysis. JAMA 2003; 289: 2534-2544.
3. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041.
4. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-Analysis. BMJ 2003; 326: 1423.
5. Department of Health. Putting prevention first -vascular checks: risk assessment and management. London: DH, 2008.
6. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419.
7. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-Analysis. Hypertension 2010; 55: 399-407.
8. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-Analysis. Am J Med 2007; 120: 713-719.
9. Soliman EZ, Mendis S, Dissanayake WP, et al. A polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health Organization. Trials 2011; 12: 3.
10. Williams B, Shaw A, Durrant R, et al. Patient perspectives on multiple medications versus combined pills: a qualitative study. QJM 2005; 98: 885-893.
11. Fung V, Sinclair F, Wang H, et al. Patients' perspectives on nonadherence to statin therapy: a focus-group study. Perm J 2010; 14(1): 4-10.
12. Mann DM, Allegrante JP, Natarajan S, et al. Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther 2007; 21: 311-316.
13. Shiri C, Srinivas SC, Futter WT, Radloff SE. The role of insight into and beliefs about medicines of hypertensive patients. Cardiovasc J Afr 2007; 18: 353-357.
14. Benson J, Britten N. Patients' views about taking antihypertensive drugs: questionnaire study. BMJ 2003; 326: 1314-1315.
15. Morecroft C, Cantrill J, Tully MP. Patients' evaluation of the appropriateness of their hypertension management: a qualitative study. Res Social Adm Pharm 2006; 2(2): 186-211.
16. Benson J, Britten N. Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ 2002; 325: 873.
17. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 14(1): 1-24.
18. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-567.
19. Mardby AC, Akerlind I, Hedenrud T. General beliefs about medicines among doctors and nurses in out-patient care: a cross-sectional study. BMC Fam Pract 2009; 10: 35.
20. Kumar K, Gordon C, Toescu V, et al. Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin. Rheumatology 2008; 47(5): 690-697.
21. Ritchie J, Lewis J. Qualitative research practice: a guide for social science students and researchers. London: Sage Publications, 2003.
22. Chenail RJ. Interviewing the investigator: strategies for addressing instrumentation and researcher bias concerns in qualitative research. Qualitative Report 2011; 16(1): 255-262.
23. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ 1995; 311: 42-45.
24. Glaser BG. The constant comparative method of qualitative analysis. Soc Probl 1965; 12: 436-445.
25. Stevenson FA, Barry CA, Britten N, et al. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med 2000; 50: 829-840.
26. Polit DF, Beck CT. Generalization in quantitative and qualitative research: myths and strategies. Int J Nurs Stud 2010; 47: 1451-1458.
27. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006; 18(1): 59-82.
28. Erhardt LR. Managing cardiovascular risk: reality vs. perception. Eur Heart J Suppl 2005; 7(L): L11-L15.
29. Weinstein ND. Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med 1987; 10: 481-500.
30. Webster R, Heeley E. Perceptions of risk: understanding cardiovascular disease. Risk Manag Healthc Policy 2010; 3: 49-60.
31. Gale NK, Greenfield S, Gill P, et al. Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study. BMC Fam Pract 2011; 12: 59.
32. Virdee SK, Greenfield SM, Fletcher K, et al. Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study. BMJ Open 2013; 3(3). DOI: 10.1136/bmjopen-2012-002498.
33. Rashid MA, Edwards D, Walter FM, Mant J. Medication taking in coronary artery disease: a systematic review and qualitative synthesis. Ann Fam Med 2014; 12: 224-232.
34. Thom S, Poulter N, Field J, et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA 2013; 310: 918-929.